Health-related quality of life (HRQoL) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in combination with abiraterone
Thiery-Vuillemin, A Wiechno, PJ Alekseev, B Sala, N Jones, R Kocak, I Chiuri, VE Jassem, J Flechon, A
Thiery-Vuillemin, A
Wiechno, PJ
Alekseev, B
Sala, N
Jones, R
Kocak, I
Chiuri, VE
Jassem, J
Flechon, A
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Clarke NW, Thiery-Vuillemin A, Wiechno PJ, Alekseev B, Sala N, Jones R, et al. Health-related quality of life (HRQoL) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in combination with abiraterone. J Clin Oncol. 2019;37(7_suppl):234-.